Abstract KIR2DL5 alleles were physically linked to alleles at adjacent KIR loci to define this region of KIR haplotypes in 55 gene-positive random African Americans. The majority carried KIR2DL5B. Three KIR2DL5A and six KIR2DL5B alleles that have been previously described and 11 novel KIR2DL5 alleles were identified by DNA sequencing. Novel alleles included variation that may impact promoter activity; two alleles carried nonsynonymous coding region variation. Based on linkage with KIR2DS1, KIR2DS3, KIR2DS5, KIR2DL2, KIR2DL3, and KIR3DS1 alleles, seven haplotypes of KIR2DL5A and 23 haplotypes of KIR2DL5B were observed. The phylogenetic relationships among the KIR2DL5 alleles predicted their association with either KIR2DS3 (six alleles) or KIR2DS5 (seven alleles). All of the KIR2DL5A alleles were linked either to KIR3DS1*01301 or KIR3DS1*049N. The majority of the KIR2DL5B alleles were linked to seven KIR2DL2 alleles; two were linked to a novel allele of KIR2DL3.
Introduction
The human natural killer cell immunoglobulin-like receptor (KIR) KIR2DL5 gene arises from an ancient lineage with orthologs identified in nonhuman primates (Hershberger et al. 2005; Khakoo et al. 2000; Rajalingam et al. 2004 ). KIR2DL5 is classified as an inhibitory receptor, but its ligand is not yet known Yusa et al. 2004) . Its D0-D2 domain structure (specified by exons 3 and 5 in the absence of exon 4) distinguish it and KIR2DL4 from the other two domain KIR that are characterized by a D1-D2 structure (specified by exons 4 and 5 with the inactivation of exon 3; Vilches et al. 2000b) .
The gene encoding KIR2DL5 is duplicated in some KIR haplotypes (Gomez-Lozano et al. 2002) . KIR2DL5B lies in the centromeric region of the KIR gene complex, flanked by KIR2DL2 (or KIR2DL3) at its 5′ end and by KIR2DS3 (or KIR2DS5) at its 3′ end (Du et al. 2008; Ordonez et al. 2008) . KIR2DL5A lies in the telomeric region flanked by KIR3DS1 (5′) and KIR2DS3 (or KIR2DS5) and KIR2DS1 (3′). The KIR2DL5 gene is usually found in a subset of KIR haplotypes designated as B which are marked by an increased activating KIR gene content Marsh et al. 2003a) .
Both KIR2DL5A and KIR2DL5B are polymorphic, encoding eight and 13 alleles, respectively (IPD-KIR database release 2.1.0; Robinson et al. 2010 ). Many of the Electronic supplementary material The online version of this article (doi:10.1007/s00251-010-0458-8) contains supplementary material, which is available to authorized users.
KIR2DL5B alleles are not expressed due to variation in transcription factor binding sites, including runt-related transcription factor-3 (RUNX3; also known as AML2; Vilches et al. 2000a; Vilches et al. 2000b) , Yin Yang 1 (YY1) and specificity protein 1 (Sp1; Davies et al. 2007; Li et al. 2008) . Variation in the balance between forward and reverse transcripts impacted by allelic polymorphism alters expression levels. Reduced promoter activity may lead to epigenetic silencing mediated by methylation (GomezLozano et al. 2007) .
The purpose of this study was to evaluate 2DL5 allelic diversity in an African American population and to identify alleles at flanking loci to define this region of KIR haplotypes.
Materials and methods
Human studies were approved by the Georgetown University Institutional Review Board and conform to standards laid down in the 1964 Declaration of Helsinki. Genomic DNA was isolated from Epstein Barr virus-transformed Bcell lines from 100 unique and unrelated African Americans from the National Institute of General Medical Sciences Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/nigms/) using a QIAamp® DNA Blood Mini Kit (Qiagen, Valencia, CA). Characterization of the KIR2DS1, KIR2DS3, KIR2DS5, and KIR3DS1 alleles carried in this population has already been reported (Hou et al. 2009; Jiang et al. 2010) . The strategy for KIR2DL5 allele characterization has been described previously; two overlapping amplicons cover the 5′ upstream region from −274 through the 3′UTR (Mulrooney et al. 2008) . KIR2DL2/2DL3 alleles were identified by the DNA sequencing of overlapping amplicons using PCR primers listed in supplemental Table 1 . An exception was KIR2DL3 amplicons B and C where one of the two PCR primers yielding each amplicon annealed in intron 5 but did not produce overlapping fragments. In some cases, other closely related KIR loci coamplified with some of the amplicons and required additional strategies. KIR2DL2-999T and KIR2DL3-1316T HaploPrep TM separation kits (Qiagen, Valencia, CA) were used to isolate specific KIR2DL2/2DL3 alleles from those cell lines shown to carry KIR2DL1, KIR2DS2, or both KIR2DL2 and KIR2DL3. Probe 2DL2-999T targets nucleotide position 708 in exon 6 shared by all known KIR2DL2 alleles except KIR2DL2*004 and absent from KIR2DL3. The probe 2DL3-1316T targets nucleotide 1,024 in exon 9 which is found in all alleles of KIR2DL3 but not in KIR2DL2. Cleavage of KIR2DP1 with the restriction enzyme BclI eliminated its coamplification with amplicon A of KIR2DL3 and reduced the background observed in sequencing amplicon B. Genomic DNA (2 µg) was digested using 3 ul Bc1I (15 Units/ul; New England BioLabs, Ipswich, MA) in 1× NE buffer 3 in a total volume of 200 ul at 50°C for 1 h. DNA was isolated using phenol/ chloroform and ethanol precipitation and PCR amplification performed as described.
KIR2DL5 and KIR2DL2/KIR2DL3 amplicons were purified using AmPure magnetic beads (Agencourt Bioscience, Beverly, MA). Sequencing was performed using Applied Biosystems' BigDye Terminator Ready Reaction mix (Applied Biosystems, Foster City, CA). Sequencing primers were positioned to obtain the sequence of both strands of each amplicon (supplemental Table 2 for KIR2DL2/2DL3; Mulrooney et al. 2008) . Some of the primers for KIR2DL2/2DL3 were specific for polymorphisms that distinguished alleles and/or reduced the background from contaminating loci. The reactions were purified using CleanSEQ (Agencourt Bioscience). Sequencing products were detected using an Applied Biosystems 3730XL DNA analyzer. Sample files were analyzed using Sequencher (Genecodes Corp., Ann Arbor, MI) and Assign SBT 3.2.7 (Conexio Genomics, Applecross, Western Australia) software. Sequences were compared with known KIR sequences obtained from the IPD-KIR database version 2.1.0 to determine allelic assignments. Proximal promoter 
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Most similar allele => novel allele sequences were compared with known KIR sequences from sources previously described (Mulrooney et al. 2008) . In this report, the numbering of nucleotides and codons are based on IPD-KIR unless noted. In heterozygotes, novel alleles were isolated using allele specific amplification, HaploPrep kits (Qiagen, Valencia, CA) or by cloning and characterized by DNA sequencing. Allele designations for novel alleles were assigned by the WHO Nomenclature Committee for Factors of the HLA System (Marsh et al. 2003b) .
Adjacent genes, KIR2DS3, KIR2DS5, and KIR2DS1, were identified in all KIR2DL5-positive cells by extracting DNA fragments with probes 2DS3-867A, 2DS5-493C, or 2DS1-563A (HaploPrep) followed by detection of KIR2DL5 on the fragment by sequencing. Long-range PCR was used to link KIR3DS1 or KIR2DL2/2DL3 to KIR2DL5 alleles in cases of a novel allele or a novel allele combination defining a haplotype using a sense primer annealing in the 5′ gene (3DS1-SSPF-GGCAGAATA TTCCAGGAGG, 2DL2-E6F-708T-TCACCCACTG A A C C A A G C T C T, a n d 2 D L 3 -S S P F -C C T T CATCGCTGGTGCTG) and an antisense primer annealing in KIR2DL5 (GGGGTCACAGGGCCCATGAGGAT). Haplotype specific extraction was also used to link KIR2DL2/2DL3 or KIR3DL1/KIR3DS1 to KIR2DL5 using probes 2DL2-999 T, 2DL3-1316 T, 3DL1-1156C, 3DS1-556 T, and 2DL5-784A (HaploPrep).
The nucleotide sequences of KIR2DL5 were aligned by MUSCLE (Edgar 2004) , and a maximum likelihood tree was built using PHYML (version 3.0, BIONJ distancebased tree as the starting tree, GTR as the substitution model; Guindon and Gascuel 2003) .
Results

KIR2DL5B
predominates in a population with high KIR2DL5 allelic diversity Fifty-five of 100 random African Americans carried KIR2DL5; 31% carried KIR2DL5A, and 82% carried KIR2DL5B. This is consistent with the distribution previously observed in a population of 32 African Americans (Du et al. 2008) . In contrast, in European Americans, the majority of KIR2DL5-positive individuals carry KIR2DL5A (83%) compared with KIR2DL5B (49%; Mulrooney et al. 2008) . Sequencing of 254 base pairs of the 5′ upstream region and the entire coding region of KIR2DL5 identified three known KIR2-DL5A alleles, six known KIR2DL5B alleles, and 11 novel alleles (Table 1) . A comparison with a similar study in European Americans (n=74; Mulrooney et al. 2008) shows three alleles present in >10% of gene-positive individuals in African Americans and four in European Americans; two of these frequent alleles (KIR2DL5A*0010101 found in 22% of African Americans and 63% of European Americans; KIR2DL5B*0020101 found in 33% and 29%, respectively) a r e c o m m o n i n b o t h p o p u l a t i o n s . F r e q u e n t KIR2DL5B*00601 (20%) in African Americans was not o b s e r v e d i n E u r o p e a n A m e r i c a n s ; f r e q u e n t KIR2DL5B*0020102 (14%) in European Americans was not observed in African Americans. Seventeen alleles are found at frequencies <10%-each of these alleles was found in one to three African American individuals. In contrast, in European Americans, three alleles at frequencies <10% were found in single individuals. Thus, African Americans appear to carry a broader spectrum of KIR2DL5 alleles compared with a European American population. 
AGC (S)=>AAT (N), 282 TAT (Y) => TAC (Y) GU573764
a The names of alleles are assigned by the World Health Organization Nomenclature Committee for Factors of the HLA System (Marsh et al. 2003b) The identity of the 11 novel alleles as KIR2DL5A versus KIR2DL5B was determined by sequence homology to known alleles and by physically linking the new allele to its 5′ neighboring gene, either to KIR3DS1 for KIR2DL5A or to KIR2DL2 (or KIR2DL3) for KIR2DL5B . Novel alleles differing in their coding sequences included KIR2DL5A*01201 with a substitution in the signal peptide and KIR2DL5B*01301 with a substitution in the second extracellular domain (Table 2 ). Six alleles had synonymous substitutions including variants of the two novel alleles described above.
Six of the novel alleles exhibited variation in their 5′ upstream regions from their most similar allele. Four of these alleles, all KIR2DL5B alleles, join KIR2DL5B*003 in carrying the expressed version of the RUNX3 site: KIR2DL5B*0020106, *00202, *0070102, and *01303. Furthermore, two of these alleles, KIR2DL5B*0020106 and KIR2DL5B*0070102, exhibit identical nucleotide changes which alter the binding sites for transcription factors key in the regulation of KIR expression (Davies et al. 2007; Li et al. 2008 ). Substitution at nucleotide −176 restores the sequence of the YY1 site; disruption of this site in most KIR2DL5 alleles is thought to increase the strength of the antisense promoter reducing gene expression of KIR2DL5. Variation at −27 alters an Sp1 site, creating a better consensus sequence for Sp1 binding. This latter varia tion , also foun d i n KIR2DL5B*003 and KIR2DL5B*0070101, has been shown to decrease forward promoter activity reducing expression compared with KIR2DL5A*001 (Li et al. 2008) . It is not known how these two nucleotide substitutions will impact the balance between sense and antisense transcripts, but expression may vary from the other KIR2DL5B alleles.
Eleven novel KIR2DL2/2DL3 alleles alter the amino acid sequence of the gene located 5′ of KIR2DL5B Alleles present at the KIR2DL2/2DL3 locus were identified by DNA sequencing in preparation for defining their associa- tion with KIR2DL5B alleles. In addition to six previously reported alleles, four KIR2DL2 and seven KIR2DL3 novel alleles were detected in 100 African Americans (Table 3) . Two of the four novel KIR2DL2 alleles carried single nonsynonymous substitutions altering D1 or transmembrane regions compared with their most similar alleles. Five of seven novel KIR2DL3 alleles carried one or two nonsynonymous substitutions altering D1, D2, or cytoplasmic tail regions.
Linkage defines 30 allelic haplotypes centered around KIR2DL5 Table 4 shows the linkage of KIR2DL5 alleles with alleles at nearby loci defining these centromeric and telomeric regions of the KIR haplotypes. The association with KIR2DS3 or KIR2DS5 was observed to parallel the nucleotide sequence homology as identified by a phylogenetic tree of KIR2DL5 coding sequences (Fig. 1 ). Alleles clustered with KIR2DL5B*0020101 are associated with KIR2DS3; alleles clustered with KIR2DL5A*0010101 are associated with KIR2DS5. Both KIR2DL5A and KIR2DL5B alleles and both expressed and non-expressed alleles are found in each cluster. Linkage of telomeric KIR2DL5A to specific alleles of KIR2DS3 or KIR2DS5 noted by other investigators were observed [KIR2DL5A*0010101 with KIR2DS5*00201 (11 individuals); KIR2DL5A*0050101 with KIR2DS3*002 (2 individuals)] (Middleton et al. 2007; Ordonez et al. 2008) . Three additional haplotypes of KIR2DL5A with KIR2DS5 were identified: one silent variation of KIR2-DL5A*0010101 (KIR2DL5A*00102) remains associated with KIR2DS5*00201 and two new haplotypes include novel alleles, KIR2DL5A*01201 and KIR2DL5A*01202. Five of the six KIR2DL5A haplotypes include KIR3DS1*01301; one is linked to KIR3DS1*049N. Although also found in the absence of KIR2DL5A, KIR2DS1 was found linked to KIR2DL5A in 15 of 16 individuals. The majority of haplotypes contain the predominant KIR2DS1*00201 (Middleton et al. 2007) ; one included KIR2DS1*006.
In the centromeric KIR2DL5B complex, the previously noted association of KIR2DL5B*0020101/03 with KIR2DS3*00103 (15 out of 55 KIR2DL5-positive individuals) was the most common haplotype in African Americans (Ordonez et al. 2008) . If other flanking loci were considered, 23 haplotypes of KIR2DL5B were observed: nine with KIR2DS3 and 14 with KIR2DS5. Alleles closely r e l a t e d t o K I R 2 D L 5 B * 0 0 2 0 1 0 1 / 0 3 ( e . g . , KIR2DL5B*0020104 or KIR2DL5B*010; Fig. 1 ) remain associated with KIR2DS3*00103 or its silent variants. Other alleles of KIR2DL5B are associated with a number of KIR2DS5 alleles.
The centromeric KIR2DL5B alleles are primarily associated with KIR2DL2 alleles. Seven KIR2DL2 alleles were identified in linkage with KIR2DL5B; the same alleles were found in association with haplotypes carrying either KIR2DS3 or KIR2DS5. Two haplotypes carried KIR2DL3*014 in association with two different KIR2DL5B alleles, one in association with KIR2DS3 and one with KIR2DS5.
Discussion
Few studies have explored KIR haplotype diversity at allelelevel resolution. This study of 55 KIR2DL5-positive random African Americans has detected extensive diversity at both the allelic and the haplotypic levels for KIR. Twenty KIR2DL5 alleles are embedded within 30 multi-gene complexes defining either centromeric or telomeric regions of the KIR gene cluster. These gene complexes are further differentiated by the linked alleles at neighboring loci. Specific KIR2DL5 alleles were associated either with KIR2DS3, an apparently non-expressed locus (VandenBussche et al. 2008) , or with KIR2DS5, a diverse locus in African Americans (Hou et al. 2009 ). Other sources of haplotype variability included allelic variation at KIR2DS3 (six alleles) and KIR2DS5 (seven alleles) as well as at KIR2DS1 (two alleles), KIR3DS1 (two alleles), and KIR2DL2/KIR2DL3 (eight alleles). This diversity is reminiscent of the allelic diversity of the HLA haplotypes, although the extent of allelic variation at a KIR locus is more subtle. KIR allelic products differ only modestly from one another while HLA allelic variation can be more extensive resulting in many amino acid differences.
The impact of genetic variation on the expressed KIR repertoire and the functional activity of NK cells is yet to be fully understood. The presence of specific KIR genes has been associated with susceptibility or resistance to infectious and autoimmune diseases and to malignancy (Bashirova et al. 2006; Khakoo and Carrington 2006) . In human immunodeficiency virus (HIV)-infected individuals, the presence of KIR3DS1 is associated with a delayed progression to AIDS (Martin et al. 2002a) , and KIR3DS1-expressing cells inhibit viral replication (Alter et al. 2007) . In autoimmune subjects with psoriasis, those carrying activating KIR2DS2 and KIR2DS1 are more likely to develop psoriatic arthritis than subjects without these genes (Martin et al. 2002b) . In hematopoietic progenitor cell transplantation for acute myelogenous leukemia, a decreased frequency of relapse has been noted in transplants with donors carrying haplotypes with increased numbers of activating KIR genes (i.e., KIR B haplotypes; Cooley et al. 2009) . The mechanisms by which individual KIR impact disease susceptibility, progression, and outcome is not yet clear. While resistance in diseases associated with the presence of inhibitory KIR receptors with known HLA ligands may result from a decreased activation threshold for NK cells (Khakoo et al. 2004) , the lack of information on the ligands of other KIR including KIR2DL5 hinders an understanding of mechanisms for those KIR.
Less is known about the impact of KIR allelic polymorphism on the immune response. Allelic variation alters the level of protein expression and the affinity of ligand binding as demonstrated for KIR3DL1 (Sharma et al. 2009; Yawata et al. 2008 ) and KIR2DL2/KIR2DL3 (Moesta et al. 2008) . In HIV infection, allotypic variation of KIR3DL1 influences disease progression and levels of the pathogen in plasma . In hepatitis C infections, the presence of the KIR2DL3 subset of the KIR2DL2/KIR2DL3 alleles is associated with the resolution of infection in those carrying the appropriate HLA-C ligand (Khakoo et al. 2004 ). Thus, the unique KIR haplotypes observed in the African American population, coupled with diversity in their HLA ligands, likely result in unique immune response profiles for an individual.
